Stroke risk management - Changes in mainstream practice

被引:35
作者
Kalra, L [1 ]
Perez, I [1 ]
Melbourn, A [1 ]
机构
[1] Kings Coll London, Sch Med & Dent, Clin & Hlth Serv Studies Unit, London, England
关键词
stroke prevention; risk factors; cerebral infarction;
D O I
10.1161/01.STR.29.1.53
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background-Research shows that identification and control of risk factors reduces ischemic stroke. The impact of this evidence and health initiatives on mainstream practice remains unknown. Methods-The purpose of this observational study was to investigate prior management of risk factors (hypertension, atrial fibrillation, previous stroke/transient ischemic attacks) in patients with acute cerebral infarction. Data were collected on the frequency of known risk factors before the incident stroke and their management compared with predefined criteria for appropriateness. The proportion of patients receiving treatment for risk factors before the acute episode was studied over 3 years. Results-One thousand seventy-four patients (median age, 76 years; 60% women) were included in the study over 3 years. The proportion of patients with known hypertension (41% to 46%), diabetes (12% to 13%), previous stroke or transient ischemic attack (TIA) (21% to 31%), and atrial fibrillation (16% to 21%) remained stable. Overall, approximately 45% patients with atrial fibrillation, 60% patients with hypertension, and 70% with cerebrovascular disease were being actively managed. Time trends analysis showed a significant increase in the proportion of patients being treated for risk due to known cerebrovascular disease (59% to 85%), atrial fibrillation (18% to 59%), ischemic heart disease (35% to 72%), and carotid disease (13% to 85%) between the first and third year. The proportion of patients receiving treatment for hypertension remained unchanged. Patients with preexisting symptomatic vascular disease were more likely to receive appropriate risk management compared with asymptomatic patients (72% versus 46%, P<.001). Conclusions-Although a significant number of ischemic events remain potentially preventable, there appears to be a positive trend in improved control of stroke risk.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 41 条
[1]   Stroke management in Europe [J].
Aboderin, I ;
Venables, G .
JOURNAL OF INTERNAL MEDICINE, 1996, 240 (04) :173-180
[2]   Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals [J].
Albers, GW ;
Yim, JM ;
Belew, KM ;
Bittar, N ;
Hattemer, CR ;
Phillips, BG ;
Kemp, S ;
Hall, EA ;
Morton, DJ ;
Vlasses, PH .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (20) :2311-2316
[3]   STROKE PREVENTION IN NONVALVULAR ATRIAL-FIBRILLATION - A REVIEW OF PROSPECTIVE RANDOMIZED TRIALS [J].
ALBERS, GW ;
SHERMAN, DG ;
GRESS, DR ;
PAULSETH, JE ;
PETERSEN, P .
ANNALS OF NEUROLOGY, 1991, 30 (04) :511-518
[4]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[5]  
[Anonymous], 1988, BRIT MED J, V296, P320
[6]  
[Anonymous], 1989, Stroke, V20, P1407
[7]   A PROSPECTIVE-STUDY OF ACUTE CEREBROVASCULAR-DISEASE IN THE COMMUNITY - THE OXFORDSHIRE COMMUNITY STROKE PROJECT 1981-86 .2. INCIDENCE, CASE FATALITY RATES AND OVERALL OUTCOME AT ONE YEAR OF CEREBRAL INFARCTION, PRIMARY INTRACEREBRAL AND SUBARACHNOID HEMORRHAGE [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (01) :16-22
[8]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[9]  
BARNETT HJ, 1993, NEW ENGL J MED, P328
[10]   DRUG-THERAPY - DRUGS AND SURGERY IN THE PREVENTION OF ISCHEMIC STROKE [J].
BARNETT, HJM ;
ELIASZIW, M ;
MELDRUM, HE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :238-248